North America Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028

TABLE 1 North America Biosimilars Market, 2018 - 2021, USD Million
TABLE 2 North America Biosimilars Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Biosimilars Market
TABLE 4 Product Launches And Product Expansions– Biosimilars Market
TABLE 5 Acquisition and Mergers– Biosimilars Market
TABLE 6 Approvals and Trials – Biosimilars Market
TABLE 7 North America Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 8 North America Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 9 North America Oncology Diseases Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Oncology Diseases Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Blood Disorders Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Blood Disorders Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Chronic & Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Chronic & Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 18 North America Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 19 North America Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Granulocyte-Colony Stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Granulocyte-Colony Stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Insulin Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Insulin Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Biosimilars Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Biosimilars Market by Country, 2022 - 2028, USD Million
TABLE 33 US Biosimilars Market, 2018 - 2021, USD Million
TABLE 34 US Biosimilars Market, 2022 - 2028, USD Million
TABLE 35 US Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 36 US Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 37 US Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 38 US Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 39 Canada Biosimilars Market, 2018 - 2021, USD Million
TABLE 40 Canada Biosimilars Market, 2022 - 2028, USD Million
TABLE 41 Canada Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 42 Canada Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 43 Canada Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 44 Canada Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 45 Mexico Biosimilars Market, 2018 - 2021, USD Million
TABLE 46 Mexico Biosimilars Market, 2022 - 2028, USD Million
TABLE 47 Mexico Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 48 Mexico Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 49 Mexico Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 50 Mexico Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 51 Rest of North America Biosimilars Market, 2018 - 2021, USD Million
TABLE 52 Rest of North America Biosimilars Market, 2022 - 2028, USD Million
TABLE 53 Rest of North America Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 54 Rest of North America Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 55 Rest of North America Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 56 Rest of North America Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 57 key information – Fresenius SE & Co. KGaA
TABLE 58 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 59 Key Information – Pfizer, Inc.
TABLE 60 Key Information – Amgen, Inc.
TABLE 61 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 62 Key Information – Eli Lilly And Company
TABLE 63 KEY INFORMATION - MERCK & CO., INC.
TABLE 64 Key Information – Novartis AG
TABLE 65 Key Information – Biocon Limited
TABLE 66 Key Information – Intas Pharmaceutical Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2018, Jan – 2022, Aug) Leading Players
FIG 5 Recent strategies and developments: Fresenius SE & Co. KGaA
FIG 6 Recent strategies and developments: Dr. Reddy’s Laboratories Ltd.
FIG 7 Recent strategies and developments: Pfizer, Inc.
FIG 8 Recent strategies and developments: Amgen, Inc.
FIG 9 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 10 Recent strategies and developments: Novartis AG
FIG 11 Recent strategies and developments: Biocon Limited
FIG 12 Recent strategies and developments: Intas Pharmaceutical Ltd.